Type 2 diabetes mortality rate
Pro Research Analysisby 
Searched over 200M research papers
Type 2 Diabetes Mortality Rate: A Comprehensive Analysis
Overview of Type 2 Diabetes Mortality Rates
Type 2 diabetes mellitus (T2DM) is a chronic condition that significantly impacts mortality rates globally. Research indicates substantial variability in mortality rates among individuals with T2DM, influenced by factors such as age, comorbidities, and geographic location.
Variability in Mortality Rates in Clinical Trials
A comprehensive analysis of randomized controlled trials (RCTs) involving subjects with T2DM revealed a wide range of annualized mortality rates, from 0.28 to 8.24 per 100 patient-years. This 29-fold difference is attributed to variations in patient demographics and health conditions, particularly the presence of chronic kidney disease and cardiovascular morbidity . Patients with renal complications, such as proteinuria or reduced renal function, exhibited the highest mortality rates .
Regional Differences in Mortality Rates
Latin America and the Caribbean
In Latin America and the Caribbean (LAC), the proportion of all-cause mortality attributable to T2DM increased significantly from 12.2% to 16.9% in men and from 14.5% to 19.3% in women between 1985 and 2014. In 2019, the absolute number of deaths due to T2DM was 349,787 in men and 330,414 in women, with the highest death rates observed in Saint Kitts and Nevis, Guyana, and Haiti . This highlights the substantial burden of T2DM in these regions and underscores the need for improved early diagnosis and management strategies.
Nigeria
In Nigeria, the prevalence of T2DM has increased dramatically, with age-adjusted rates rising from 2.0% in 1990 to 5.7% in 2015. The overall mortality rate was found to be 30.2 per 100,000 population, with a case fatality rate of 22.0%. Common complications leading to hospital admissions and increased mortality included hyperglycemic emergencies, diabetic foot, and cardiovascular diseases .
Sweden
In Sweden, a study of patients registered in the Swedish National Diabetes Register from 1998 to 2012 showed a significant decline in mortality rates among individuals with T2DM. However, the reduction in fatal outcomes was less pronounced compared to the general population, particularly among those with poor glycemic control and severe renal complications 45.
Hong Kong
A large-scale study in Hong Kong involving over 360,000 individuals with T2DM found that younger patients (aged 18-54) had a higher relative risk of mortality associated with major comorbidities and modifiable risk factors compared to older patients. Suboptimal blood pressure was identified as the leading risk factor for all-cause mortality in younger individuals, while chronic kidney disease and cardiovascular disease were predominant in older age groups .
Ethnic Disparities in Mortality Rates
New Zealand
In New Zealand, a longitudinal cohort study revealed significant ethnic disparities in mortality rates among patients with T2DM. Māori and Pacific populations exhibited higher hospital admission rates and mortality compared to European patients. Despite similar trends in decreasing mortality over time, Māori patients had higher adjusted incidence rate ratios for all-cause, cardiovascular, and cancer mortality .
Trends in Mortality Rates Over Time
Australia
An analysis of over one million Australians with diabetes from 2000 to 2011 showed a decrease in all-cause, cardiovascular, and diabetes-specific mortality rates for both type 1 and type 2 diabetes. However, younger populations did not experience the same improvements as older populations, and cancer mortality rates remained unchanged .
United Kingdom
In the United Kingdom, a study of individuals diagnosed with T2DM between 1996 and 2006 indicated a consistent decrease in relative mortality over time. This trend suggests improvements in diabetes management and healthcare interventions .
Conclusion
The mortality rate among individuals with type 2 diabetes varies widely based on demographic factors, comorbidities, and geographic regions. While some regions have seen improvements in mortality rates due to better management and healthcare policies, significant disparities remain, particularly among younger populations and ethnic minorities. Addressing these disparities through targeted interventions and early management strategies is crucial to reducing the global burden of type 2 diabetes.
Sources and full results
Most relevant research papers on this topic